Form 4 for BSX Boston Scientific
Accepted 2025-02-18 00:00:00 ET · period of report 2025-02-13 · accession 0001225208-25-001866 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-18 | 2025-02-14+ | BSX | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | F - Tax | $106.11 | -4,080 | 19.4K | -17% | -$432.9K |
| DM | 2025-02-18 | 2025-02-14+ | BSX | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | M - OptEx | $0.00 | +8,552 | 20.9K | +69% | $0 |
| DM | 2025-02-18 | 2025-02-14+ | BSX | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | M - OptEx | $0.00 | -8,552 | 6,346 | -57% | $0 |
| DM | 2025-02-18 | 2025-02-13 | BSX | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | A - Grant | $0.00 | +32.0K | 8,950 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-16 | F | D | 1,231 | $106.11 | 20,716 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-17 | M | A | 2,834 | $0.00 | 23,550 | D | — | — | (F1) Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. |
| 3 | Common | Common Stock | 2025-02-17 | F | D | 1,315 | $106.11 | 22,235 | D | — | — | |
| 4 | Common | Common Stock | 2025-02-16 | M | A | 2,546 | $0.00 | 21,947 | D | — | — | (F1) Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. |
| 5 | Common | Common Stock | 2025-02-14 | M | A | 3,172 | $0.00 | 20,935 | D | — | — | (F1) Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. |
| 6 | Common | Common Stock | 2025-02-14 | F | D | 1,534 | $106.11 | 19,401 | D | — | — | |
| 7 | Derivative | Restricted Stock Units | 2025-02-16 | M | D | 2,546 | $0.00 | 2,546 | D | — · — to 2026-02-16 | 2,546 Common Stock | (F1) Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. (F6) Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant. |
| 8 | Derivative | Restricted Stock Units | 2025-02-17 | M | D | 2,834 | $0.00 | 0 | D | — · — to 2025-02-17 | 2,834 Common Stock | (F1) Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. (F7) Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant. |
| 9 | Derivative | Restricted Stock Units | 2025-02-14 | M | D | 3,172 | $0.00 | 6,346 | D | — · — to 2027-02-14 | 3,172 Common Stock | (F1) Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. (F5) Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant. |
| 10 | Derivative | Stock Option (Right to Buy) | 2025-02-13 | A | A | 23,031 | $0.00 | 23,031 | D | $106.14 · — to 2035-02-13 | 23,031 Common Stock | (F4) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant. |
| 11 | Derivative | Restricted Stock Units | 2025-02-13 | A | A | 8,950 | $0.00 | 8,950 | D | — · — to 2029-02-13 | 8,950 Common Stock | (F1) Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. (F3) Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant. |